Episode Details

Paul didn't stumble into biotech, he was pulled in by a diagnosis. When a doctor told his daughter to prepare for a life without her sight due to retinitis pigmentosa, he went all in on finding the best science out there to give patients like her new hope.

Today he leads Ray Therapeutics, who're developing optogenetic gene therapies designed to restore vision, not just slow its loss, for patients who are already out of other options. We talk about the science, the personal mission, and what's coming next.